AVODART

AVODART, developed by Waylis Therapeutics Llc, is an RX oral capsule used to treat Benign Prostatic Hyperplasia (BPH). It helps improve urinary flow and shrink the prostate over time for men with enlarged prostates. Administered daily, it's not available OTC.

Manufacturer

Waylis Therapeutics Llc

Formulation

oral / capsule

Active: dutasteride

Approved

11/20/2001

Expires

Unavailable

Primary Indication

benign prostatic hyperplasia

Manageable Constraints

ACNU Feasibility

View full report

Avodart (dutasteride) is an oral capsule with moderate side effects, low overdose risk, and minimal misuse potential. It requires careful monitoring, especially in special populations, and has dosing simplicity but delayed effects that may affect adherence.